It looks like you are not a member of VIP Club yet. Please fill out the form below to access the page and join the VIP Club
By Jazmin Goodwin, CNN Business Gilead Sciences will acquire biopharmaceutical company Immunomedics for $21 billion, the company announced on Sunday. The acquisition will expand Gilead's portfolio of treatments for…